心脏骤停后脑氧饱和度与神经功能良好生存的相关性:一项多中心研究
这项前瞻性研究纳入美国与英国九家急性病医院的87例院内心脏骤停后入住ICU的患者,在骤停后48小时内用近红外光谱监测额叶局部脑氧饱和度(rSO2)。主要终点为出院时存活且神经功能良好(CPC 1–2)对比严重神经损伤或死亡(CPC 3–5),26例(29.9%)达到CPC 1–2。CPC 1–2组与CPC 3–5组在骤停后1–2小时的平均rSO2有显著差异(73.08 vs 66.59,p=0.031),其他时间区间无差异,两组年龄、Charlson合并症指数、APACHE II评分、CPR时长、平均动脉压、PaO2、PaCO2和血红蛋白水平均无差异。作者结论认为可能存在生理学差异,但该差异可能无临床意义。
要点
- 院内心脏骤停后1–2小时rSO2在CPC 1–2组为73.08、CPC 3–5组为66.59,两组差异p=0.031。
- 骤停后6–12小时、12–18小时、18–24小时及24–48小时的rSO2在两组间无显著差异。
- 87例患者中26例(29.9%)出院时达到CPC 1–2。
- 两组年龄、Charlson合并症指数、APACHE II评分、CPR时长、平均动脉压、PaO2、PaCO2和血红蛋白水平均无差异。
- 作者认为1–2小时rSO2的差异可能存在生理学意义,但可能无临床意义。
适用人群与场景
- 美国与英国九家急性病医院中院内心脏骤停后入住ICU并存在心脏骤停后综合征的患者。
- 为便利样本,非连续纳入。
诊断标准与关键阈值
- 主要终点分组:出院时脑功能表现分级(CPC)1–2为神经功能良好生存,CPC 3–5为严重神经损伤或死亡。
处置流程与药物剂量
- 院内心脏骤停后48小时内使用脑氧饱和度监测仪(Equanox 7600,Nonin Medical,MN,USA)监测额叶rSO2。
- rSO2取各时间区间收集数据的均值:1–6小时每小时、6–12小时、12–18小时、18–24小时和24–48小时。
研究设计与关键结果
- 前瞻性研究,纳入87例院内心脏骤停后入住ICU的患者,来自美国与英国九家急性病医院。
- 26例(29.9%)出院时达到CPC 1–2。
- 骤停后1–2小时平均rSO2:CPC 1–2组73.08 vs CPC 3–5组66.59,p=0.031。
- 其他时间区间两组rSO2无显著差异。
- 两组年龄、Charlson合并症指数、APACHE II评分、CPR时长、平均动脉压、PaO2、PaCO2和血红蛋白水平均无差异。
证据类型、等级与局限
- 证据类型:前瞻性研究。
- 作者结论:院内心脏骤停患者恢复自主循环后前两小时rSO2在达到神经功能良好结局者中可能存在显著生理学差异,但该差异可能无临床意义。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为院内心脏骤停后1–2小时rSO2的差异可能存在生理学意义但可能无临床意义,原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Cerebral oximetry is a non-invasive system that uses near infrared spectroscopy to measure regional cerebral oxygenation (rSO2) in the frontal lobe of the brain. Post-cardiac arrest rSO2 may be associated with survival and neurological outcomes in out-of-hospital cardiac arrest patients; however, no studies have examined relationships between rSO2 and neurological outcomes following in-hospital cardiac arrest (IHCA). We tested the hypothesis that rSO2 following IHCA is associated with survival and favorable neurological outcomes.
DESIGN: Prospective study from nine acute care hospital in the United States and United Kingdom.
PATIENTS: Convenience sample of IHCA patients admitted to the intensive care unit with post-cardiac arrest syndrome.
INTERVENTIONS: Cerebral oximetry monitoring (Equanox 7600, Nonin Medical, MN, USA) during the first 48 h after IHCA.
MEASUREMENTS AND MAIN RESULTS: Subject's rSO2 was calculated as the mean of collected data at different time intervals: hourly between 1-6 h, 6-12 h, 12-18 h, 18-24 h and 24-48 h. Demographic data pertaining to possible confounding variables for rSO2 and primary outcome were collected. The primary outcome was survival with favorable neurological outcomes (cerebral performance scale [CPC] 1-2) vs severe neurological injury or death (CPC 3-5) at hospital discharge. Univariate and multivariate statistical analyses were performed to correlate cerebral oximetry values and other variables with the primary outcome. Among 87 studied patients, 26 (29.9%) achieved CPC 1-2. A significant difference in mean rSO2 was observed during hours 1-2 after IHCA in CPC 1-2 vs CPC 3-5 (73.08 vs. 66.59, p = 0.031) but not at other time intervals. There were no differences in age, Charlson comorbidity index, APACHE II scores, CPR duration, mean arterial pressure, PaO2, PaCO2, and hemoglobin levels between two groups.
CONCLUSIONS: There may be a significant physiological difference in rSO2 in the first two hours after ROSC in IHCA patients who achieve favorable neurological outcomes, however, this difference may not be clinically significant.
参考来源
- Tran LN, Patel J, Yang J, et al. The association between post-cardiac arrest cerebral oxygenation and survival with favorable neurological outcomes: A multicenter study. Resuscitation. 2020. PMID: 32544414. doi:10.1016/j.resuscitation.2020.06.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。